Patent AT-E400586-T1: [Translated] RECEPTORS FOR HUMAN INTERLEUKIN-12
Description
The present disclosure is directed to IL-12 receptor proteins comprising a complex of the beta1 receptor protein with the beta2 receptor protein, which complex is capable of binding to human IL-12 with high affinity. When expressed in host cells the nucleic acid gives rise to substantially homogeneous IL-12 receptor proteins. The invention relates to antibodies capable of binding to cells expressing the IL-12 receptor molecules for use in the treatment of an autoimmune dysfunction.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400586-T1: [Translated] RECEPTORS FOR HUMAN INTERLEUKIN-12 on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400586-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem